ImageneBio (IMA) Income from Continuing Operations (2020 - 2024)
Historic Income from Continuing Operations for ImageneBio (IMA) over the last 5 years, with Q4 2024 value amounting to -$17.5 million.
- ImageneBio's Income from Continuing Operations rose 1105.8% to -$17.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$50.5 million, marking a year-over-year increase of 2603.76%. This contributed to the annual value of -$49.2 million for FY2024, which is 2777.34% up from last year.
- According to the latest figures from Q4 2024, ImageneBio's Income from Continuing Operations is -$17.5 million, which was up 1105.8% from -$3.2 million recorded in Q3 2024.
- ImageneBio's Income from Continuing Operations' 5-year high stood at $2.8 million during Q4 2021, with a 5-year trough of -$26.1 million in Q4 2020.
- For the 5-year period, ImageneBio's Income from Continuing Operations averaged around -$13.3 million, with its median value being -$14.4 million (2021).
- Its Income from Continuing Operations has fluctuated over the past 5 years, first surged by 11073.58% in 2021, then plummeted by 60400.43% in 2022.
- Over the past 5 years, ImageneBio's Income from Continuing Operations (Quarter) stood at -$26.1 million in 2020, then surged by 110.74% to $2.8 million in 2021, then tumbled by 604.0% to -$14.1 million in 2022, then plummeted by 39.4% to -$19.7 million in 2023, then rose by 11.06% to -$17.5 million in 2024.
- Its Income from Continuing Operations was -$17.5 million in Q4 2024, compared to -$3.2 million in Q3 2024 and -$13.7 million in Q2 2024.